EXCERPT:
MAKARY: "Well a lot of experts have been against it because there is no real data that the fourth dose is reducing the risk of hospitalization. What it does is it takes an infection that's inevitable in the population, and it transiently gives you protection for a couple months. And with Omicron, that protection goes down to 11, 13, 16 percent after 3 to 6 months. So, remember this was a vaccine designed for the Wuhan strain, not for the current strain. It doesn't work that well. And your protection against severe illness is still solid with the primary vaccine series, the third dose in people over 65, and with natural immunity. And right now the experts are not on board. So what they did is they bypassed them, they chose not to convene them, they didn't have them vote, instead they're going to have them discuss it after it’s authorized. It'd be like a judge giving a verdict and then saying the lawyers can discuss it after the fact."